Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity

Acute myeloid leukemia (AML) has a poor prognosis and a heterogeneous mutation landscape. Although common mutations are well-studied, little research has characterized how the sequence of mutations relates to clinical features. Using published, single-cell DNA sequencing data from three institutions, we compared clonal evolution patterns in AML to patient characteristics, disease phenotype, and outcomes. Mutation trees, which represent the order of select mutations, were created for 207 patients from targeted panel sequencing data using 1 639 162 cells, 823 mutations, and 275 samples. In 224 distinct orderings of mutated genes, mutations related to DNA methylation typically preceded those related to cell signaling, but signaling-first cases did occur, and had higher peripheral cell counts, increased signaling mutation homozygosity, and younger patient age. Serial sample analysis suggested that NPM1 and DNA methylation mutations provide an advantage to signaling mutations in AML. Interestingly, WT1 mutation evolution shared features with signaling mutations, such as WT1-early being proliferative and occurring in younger individuals, trends that remained in multivariable regression. Some mutation orderings had a worse prognosis, but this was mediated by unfavorable mutations, not mutation order. These findings add a dimension to the mutation landscape of AML, identifying uncommon patterns of leukemogenesis and shedding light on heterogenous phenotypes.

Errataetall:

UpdateIn: Leukemia. 2024 Mar 11;:. - PMID 38467769

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - year:2023

Enthalten in:

Research square - (2023) vom: 06. Nov.

Sprache:

Englisch

Beteiligte Personen:

Schwede, Matthew [VerfasserIn]
Jahn, Katharina [VerfasserIn]
Kuipers, Jack [VerfasserIn]
Miles, Linde A [VerfasserIn]
Bowman, Robert L [VerfasserIn]
Robinson, Troy [VerfasserIn]
Furudate, Ken [VerfasserIn]
Uryu, Hidetaka [VerfasserIn]
Tanaka, Tomoyuki [VerfasserIn]
Sasaki, Yuya [VerfasserIn]
Ediriwickrema, Asiri [VerfasserIn]
Benard, Brooks [VerfasserIn]
Gentles, Andrew J [VerfasserIn]
Levine, Ross [VerfasserIn]
Beerenwinkel, Niko [VerfasserIn]
Takahashi, Koichi [VerfasserIn]
Majeti, Ravindra [VerfasserIn]

Links:

Volltext

Themen:

Preprint

Anmerkungen:

Date Revised 25.03.2024

published: Electronic

UpdateIn: Leukemia. 2024 Mar 11;:. - PMID 38467769

Citation Status PubMed-not-MEDLINE

doi:

10.21203/rs.3.rs-3516536/v1

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM364782153